Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS).

导出 LinkOut

翻译打印收藏纠错

作者： Scott C,Woller ^[1] ; Scott M,Stevens ^[2] ; David A,Kaplan ^[3] ; D Ware,Branch ^[4] ; Valerie T,Aston ^[5] ; Emily L,Wilson ^[6] ; Heather M,Gallo ^[5] ; Eric G,Johnson ^[5] ; Matthew T,Rondina ^[3] ; James F,Lloyd ^[7] ; R Scott,Evans ^[8] ; C Gregory,Elliott ^[2]

作者单位： Intermountain Medical Center, Murray, UT, USA Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA scott.woller@imail.org. ^[1] Intermountain Medical Center, Murray, UT, USA Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. ^[2] Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. ^[3] Intermountain Medical Center, Murray, UT, USA Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT, USA. ^[4] Intermountain Medical Center, Murray, UT, USA. ^[5] Division of Statistics, Intermountain Medical Center, Murray, UT, USA. ^[6] Department of Medical Informatics, Intermountain Healthcare, Murray, UT, USA. ^[7] Department of Medical Informatics, Intermountain Healthcare, Murray, UT, USA Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, USA. ^[8]

关键词 anticoagulants deep venous thrombosis lupus inhibitor pulmonary embolism stroke venous thromboembolism